ARCHIVES

FDA Expands Nexavar Indication To Include Thyroid Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Synar Bill Provides FDA Regulation Of Tobacco Products

March 4, 1994

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

January 27, 1989

NCI To Conduct Survey On Needs For Compliance with Biohazard Requirements

December 16, 1977

Funding Opportunities

October 4, 2002

Program Announcements. RAPID Program Date Change.

June 29, 2001

Preliminary Report Tends To Support Pill’s Association With Liver Tumors

November 19, 1976